Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Vaccines

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1744831

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1744831

Plant-based Vaccines

PUBLISHED:
PAGES: 390 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Plant-based Vaccines Market to Reach US$1.5 Billion by 2030

The global market for Plant-based Vaccines estimated at US$140.8 Million in the year 2024, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 47.8% over the analysis period 2024-2030. Bacterial Vaccines, one of the segments analyzed in the report, is expected to record a 43.0% CAGR and reach US$498.4 Million by the end of the analysis period. Growth in the Viral Vaccines segment is estimated at 54.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$38.4 Million While China is Forecast to Grow at 57.2% CAGR

The Plant-based Vaccines market in the U.S. is estimated at US$38.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$357.5 Million by the year 2030 trailing a CAGR of 57.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 40.8% and 44.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 42.1% CAGR.

Global Plant-Based Vaccines Market - Key Trends & Drivers Summarized

How Are Plants Being Engineered Into Next-Generation Vaccine Production Platforms?

Plant-based vaccines represent a frontier in biopharmaceutical innovation, wherein plants are used as biofactories to produce immunogenic proteins that trigger specific immune responses in humans or animals. These vaccines are developed by genetically engineering plants-commonly tobacco, lettuce, or potato-to express recombinant proteins such as viral antigens, bacterial toxins, or subunit fragments. The approach offers several distinct advantages: rapid scalability, room-temperature stability, and the elimination of animal-derived components or microbial fermentation systems that carry contamination risks. These attributes are particularly relevant in low-resource or pandemic-stricken settings where cold chain infrastructure and sterile production facilities are limited or unavailable.

Notable breakthroughs in plant molecular farming, including Agrobacterium-mediated transformation and viral vector systems, have significantly improved the yield and expression efficiency of target antigens in plant cells. Companies like Medicago and Kentucky BioProcessing have demonstrated the viability of plant-derived vaccines for influenza, COVID-19, and Ebola, advancing several candidates into clinical trials. Additionally, plant-based platforms can produce virus-like particles (VLPs), which closely mimic native viral structures and stimulate strong immune responses without carrying infectious material. These innovations are positioning plant-based systems as competitive alternatives to traditional egg- or cell-culture-based vaccine production methods.

Why Are Safety, Cost, and Flexibility Giving Plant-Based Vaccines a Strategic Advantage?

One of the strongest value propositions of plant-based vaccines is their favorable safety profile. Plants do not harbor human pathogens, making them inherently safer than mammalian or insect cell lines. The elimination of animal-derived components reduces the risk of zoonotic contamination and mitigates allergic or autoimmune responses. These vaccines also carry a lower likelihood of endotoxin presence compared to bacterial fermentation systems, improving overall tolerability. From a regulatory standpoint, these safety benefits are streamlining the approval process in several jurisdictions that are eager to diversify their vaccine manufacturing pipelines.

Cost-efficiency is another significant advantage. Traditional vaccine production requires expensive bioreactors, stringent aseptic conditions, and prolonged cell culture processes. In contrast, plant-based systems offer high biomass yields with minimal input costs, enabling rapid scale-up using greenhouses or vertical farming setups. This makes them highly attractive for pandemic preparedness strategies, especially in low-income countries or regions with limited access to global vaccine supply chains. Moreover, the modularity of plant expression platforms allows rapid swapping of genetic templates, enabling quick response to emerging viral variants or novel pathogens. These characteristics make plant-based vaccines not only cost-effective but strategically adaptable for global immunization programs.

Where Are the Leading Applications and Partnerships Taking Shape Globally?

The leading edge of plant-based vaccine development is concentrated in both human and veterinary health applications. Human use cases have included prophylactics against influenza, COVID-19, norovirus, and rotavirus. In the animal health space, plant-based vaccines have been developed for Newcastle disease in poultry, foot-and-mouth disease in livestock, and rabies in wild animals. These veterinary applications benefit from fewer regulatory hurdles and have provided a valuable proof-of-concept pathway for human-targeted vaccines. Research institutions and biotech startups are increasingly collaborating with agricultural universities, government health agencies, and multinational pharmaceutical companies to accelerate development timelines.

Global partnerships are playing a pivotal role. The World Health Organization and Gavi have expressed support for decentralized, cost-efficient vaccine production models, including plant-based platforms. Medicago’s collaboration with GlaxoSmithKline (GSK) for a COVID-19 vaccine candidate and Bayer’s support for plant-based pharmaceuticals indicate growing confidence from established players. In emerging economies, regional consortia are leveraging plant-based production to develop local vaccines against endemic diseases, boosting pharmaceutical sovereignty. These strategic alliances are improving regulatory frameworks, attracting capital, and promoting cross-border knowledge exchange-all of which are critical for the mainstreaming of plant-derived vaccine technology.

What’s Accelerating the Global Growth of the Plant-Based Vaccines Market?

The growth in the global plant-based vaccines market is driven by several factors, including the need for rapid, flexible, and affordable vaccine platforms in a post-pandemic world. The global COVID-19 crisis exposed significant vulnerabilities in traditional vaccine manufacturing and distribution systems, sparking interest in decentralized, scalable production methods like plant-based systems. As pandemic preparedness and vaccine equity gain global policy priority, countries are exploring plant-based platforms as part of their national biopharma strategies.

Ongoing R&D breakthroughs, regulatory fast-tracking for novel biologics, and growing investor interest are fueling pipeline growth across multiple indications. Climate resilience, low infrastructure requirements, and minimal biosafety risks make plant-based vaccines especially suitable for deployment in remote or resource-limited settings. Additionally, the potential for oral or edible vaccines-using transgenic fruits or leafy greens-is being explored as a game-changer for pediatric immunization and mass vaccination campaigns. With increasing global emphasis on biosecurity, equitable access, and cost containment, the plant-based vaccine market is poised for long-term expansion as a disruptive and humanitarian-aligned alternative to conventional vaccine systems.

SCOPE OF STUDY:

The report analyzes the Plant-based Vaccines market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Vaccine Type (Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types); Source (Tobacco Plant, Maize, Potato, Other Sources); Application (Influenza, Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Agenus Inc.
  • Akdeniz University
  • Baiya Phytopharm Co., Ltd.
  • Biodextris Inc.
  • British American Tobacco PLC
  • Calyxt Inc.
  • Creative Biolabs Inc.
  • ExpreS2ion Biotechnologies ApS
  • Fraunhofer USA Inc.
  • G+FLAS Life Sciences
  • Icon Genetics GmbH
  • iBio Inc.
  • Kentucky BioProcessing Inc.
  • LenioBio GmbH
  • Medicago Inc.
  • Panacea Biotec Limited
  • PlantForm Corporation
  • Transgene SA
  • Ventria Bioscience
  • Zyus Life Sciences Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

Show more
Product Code: MCP35538

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Plant-based Vaccines - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Focus on Scalable, Cost-Effective Vaccine Manufacturing Spurs Interest in Plant-Based Vaccine Platforms
    • Expansion of Molecular Farming Capabilities Throws the Spotlight on Transgenic and Virus-Like Particle (VLP) Production
    • Innovation in Tobacco, Lettuce, and Alfalfa-Based Expression Systems Enhances Yield and Antigen Stability
    • Growth in Zoonotic and Emerging Infectious Disease Surveillance Fuels Development of Rapid Response Plant Vaccines
    • Collaboration With Academia and Global Health Agencies Accelerates Clinical Research and Deployment
    • Increasing Need for Room-Temperature-Stable Vaccines Drives Investment in Cold Chain-Free Biologics
    • Development of Edible and Oral Vaccine Formats Expands Immunization in Resource-Limited Regions
    • Surge in Pandemic Preparedness and Biosecurity Funding Supports Investment in Alternate Vaccine Platforms
    • Participation in Regulatory and WHO-Prequalification Pathways Boosts Global Distribution Prospects
    • Advancements in Agroinfiltration and Gene Silencing Techniques Enhance Precision in Antigen Expression
    • Emphasis on Low Allergenicity and Safety Profiles Strengthens Suitability for Pediatric Use
    • Expansion of Plant-Derived Veterinary Vaccines Supports Cost-Sensitive Livestock Disease Control
    • Innovation in Rapid Antigen Switching Platforms Enables Faster Response to Mutating Pathogens
    • Growth in Interest in Personalized and Cancer Therapeutic Vaccines Expands Role of Plant-Based Carriers
    • Focus on Non-GMP Greenhouse and Vertical Farming Units Enhances Localized Biomanufacturing
    • Increasing Acceptance of Recombinant Protein Therapeutics Supports Trust in Plant-Based Modalities
    • Advances in Downstream Purification and Scalability Address Commercialization Barriers
    • Rise in Biodefense and Humanitarian Vaccine Programs Fuels Interest in Easily Deployable Plant-Based Alternatives
    • Global Harmonization of Biopharmaceutical Guidelines Strengthens Clinical Trial and Manufacturing Pathways
    • Entry Into Multi-Antigen and Combination Vaccine Development Expands Preventive and Therapeutic Applications
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Plant-based Vaccines Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Plant-based Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Plant-based Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Plant-based Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Bacterial Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Bacterial Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Bacterial Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Viral Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Viral Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Viral Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Parasite Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Parasite Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Parasite Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Vaccine Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Vaccine Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Vaccine Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Covid-19 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Covid-19 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Covid-19 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Zika Virus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Zika Virus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Zika Virus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Ebola Virus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Ebola Virus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Ebola Virus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Poultry Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Poultry Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Poultry Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Influenza by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Influenza by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Influenza by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Tobacco Plant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Tobacco Plant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Tobacco Plant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Maize by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Maize by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Maize by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Potato by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Potato by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Potato by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Other Sources by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Other Sources by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Other Sources by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Plant-based Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 47: USA Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • JAPAN
    • Plant-based Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • CHINA
    • Plant-based Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 74: China Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • EUROPE
    • Plant-based Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Plant-based Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Plant-based Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Plant-based Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • FRANCE
    • Plant-based Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 95: France Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • GERMANY
    • Plant-based Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: Germany 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: Italy 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: Italy 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Plant-based Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 122: UK Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: UK 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 128: UK Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: UK Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: UK 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Spain 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 134: Spain Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Spain Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Spain 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 137: Spain Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Spain Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Spain 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Russia 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 143: Russia Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Russia Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: Russia 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 146: Russia Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Russia Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: Russia 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Europe 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Europe Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Europe 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Plant-based Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Plant-based Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Plant-based Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Plant-based Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: Asia-Pacific 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Asia-Pacific Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: Asia-Pacific 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Plant-based Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: Australia 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 173: Australia Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Australia Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: Australia 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 176: Australia Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Australia Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: Australia 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • INDIA
    • Plant-based Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 179: India Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: India 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 182: India Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: India Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: India 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 185: India Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: India Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: India 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: South Korea 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 191: South Korea Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: South Korea Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 193: South Korea 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 194: South Korea Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: South Korea Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 196: South Korea 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Asia-Pacific Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Asia-Pacific Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Plant-based Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Plant-based Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Plant-based Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Plant-based Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 211: Latin America 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 212: Latin America Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Latin America Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 214: Latin America 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 215: Latin America Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Latin America Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 217: Latin America 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 220: Argentina 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 221: Argentina Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Argentina Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 223: Argentina 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 224: Argentina Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Argentina Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 226: Argentina 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 229: Brazil 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 230: Brazil Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Brazil Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 232: Brazil 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 233: Brazil Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Brazil Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 235: Brazil 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 238: Mexico 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 239: Mexico Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Mexico Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 241: Mexico 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 242: Mexico Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Mexico Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 244: Mexico 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Latin America Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 250: Rest of Latin America 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Rest of Latin America Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 253: Rest of Latin America 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Plant-based Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Plant-based Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Plant-based Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Plant-based Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 259: Middle East 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 260: Middle East Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Middle East Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 262: Middle East 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 263: Middle East Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Middle East Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 265: Middle East 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 268: Iran 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 269: Iran Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Iran Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 271: Iran 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 272: Iran Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Iran Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 274: Iran 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 277: Israel 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 278: Israel Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Israel Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 280: Israel 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 281: Israel Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Israel Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 283: Israel 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Saudi Arabia Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 289: Saudi Arabia 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Saudi Arabia Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 292: Saudi Arabia 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 295: UAE 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 296: UAE Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 297: UAE Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 298: UAE 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 299: UAE Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 300: UAE Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 301: UAE 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Middle East Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Middle East 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Middle East Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 310: Rest of Middle East 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
  • AFRICA
    • Plant-based Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 313: Africa 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 314: Africa Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Africa Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 316: Africa 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
    • TABLE 317: Africa Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Africa Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 319: Africa 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!